Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig 3 D
Solini GE et al. (2020)
|
Xla WT + rbpj-DBM RNA+ [bilateral]
NF 18
|
|
|
|
Fig 3 G
Solini GE et al. (2020)
|
Xla WT + rbpj-DBM RNA+ [bilateral]
NF 18
|
|
|
|
Fig 3 J
Solini GE et al. (2020)
|
Xla WT + rbpj-DBM RNA+ [bilateral]
NF 18
|
|
|
|
Fig 3 E
Solini GE et al. (2020)
|
Xla WT + rbpj-DBM RNA+ [bilateral]
NF 28
|
|
|
|
Fig 3 K
Solini GE et al. (2020)
|
Xla WT + rbpj-DBM RNA+ [bilateral]
NF 28
|
|
|
|
Fig1 B H
Solini GE et al. (2020)
|
Xla WT + rbpj-DBM RNA [unilateral]
NF 18
|
|
|
|
Fig. 1 D J
Solini GE et al. (2020)
|
Xla WT + rbpj-DBM RNA [unilateral]
NF 28
|
|
|
|
Fig. 1 C
Lichtig H et al. (2020)
|
Xla + asxl3 MO
NF16 (RT-PCR)
|
|
|
|
Fig. 4 C lane 3
Lichtig H et al. (2020)
|
Xla + asxl3 MO
NF16 (RT-PCR)
|
|
|
|
Fig. 1 B r1c2
Lichtig H et al. (2020)
|
Xla + asxl3 MO
NF18 (in situ hybridization)
|
|
|